Treponema pallidum

Treponema pallidum
Name	Treponema pallidum
Domain	Bacteria
Phylum	Spirochaetota
Class	Spirochaetia
Order	Spirochaetales
Family	Treponemataceae
Genus	Treponema
Species	T. pallidum
Binomial	Treponema pallidum
Binomial authority	Schaudinn & Hoffmann (1905)

Treponema pallidum is a spirochaete bacterium responsible for several significant human diseases, most notably syphilis. It is a fastidious, microaerophilic organism with a characteristic helical shape and corkscrew-like motility, making it difficult to culture *in vitro*. The bacterium is an obligate human pathogen, with no known animal or environmental reservoir, and its complex life cycle and ability to evade the immune system have made it a persistent public health challenge throughout history.

Description and characteristics

Treponema pallidum is a slender, spiral-shaped bacterium typically 6-15 µm in length and 0.1-0.2 µm in width, belonging to the phylum Spirochaetota. Its unique structure includes endoflagella, located in the periplasmic space, which confer its distinctive corkscrew motility, allowing it to burrow through dense tissues like the central nervous system. The organism has a remarkably small genome, sequenced by researchers at the University of Texas, containing fewer than 1.2 million base pairs and encoding approximately 1,000 proteins. It lacks many biosynthetic pathways for amino acids, fatty acids, and nucleotides, making it highly dependent on host metabolites, a characteristic identified through studies at the Rockefeller University. Its outer membrane contains a low density of transmembrane proteins, which contributes to its "stealth" pathogen status and resistance to many antibiotics.

Pathogenesis and transmission

The primary mode of transmission is through direct contact with infectious lesions during sexual activity, classifying it as a sexually transmitted infection. It can also cross the placenta, leading to congenital syphilis, and rarely, through blood transfusion or direct inoculation. Upon entry, the bacterium rapidly disseminates via the bloodstream and lymphatic system. Its pathogenesis involves adherence to host extracellular matrix components and endothelial cells, facilitated by surface proteins like Tp0751. The organism's ability to persist for decades is linked to its antigenic variation, particularly of the TprK protein, a mechanism studied at the University of Washington, which allows it to periodically evade host antibodies and establish latent infection.

Diseases caused

The most well-known disease caused by Treponema pallidum is syphilis, a complex multistage illness. The primary stage features a chancre at the inoculation site, while the secondary stage involves a systemic rash, often including the palms and soles, and lymphadenopathy. Without treatment, the infection can enter a latent phase and potentially progress to tertiary syphilis, manifesting as neurosyphilis, cardiovascular syphilis (e.g., aortitis), or destructive gummatous lesions. Other treponemal diseases include yaws (caused by subspecies pertenue), bejel (subspecies endemicum), and pinta (caused by Treponema carateum), which are non-venereal infections affecting skin and bones.

Diagnosis

Diagnosis relies on a combination of direct detection and serology. Direct methods include dark-field microscopy of exudate from lesions, a technique pioneered by Fritz Schaudinn, or direct fluorescent antibody tests. Serological testing is two-tiered: initial non-treponemal tests like the Venereal Disease Research Laboratory (VDRL) or Rapid Plasma Reagin (RPR) are followed by confirmatory treponemal tests such as the Treponema pallidum particle agglutination assay (TP-PA) or enzyme immunoassays. For neurosyphilis, diagnosis requires analysis of cerebrospinal fluid obtained via lumbar puncture, assessing white blood cell count and VDRL reactivity, as guided by the Centers for Disease Control and Prevention.

Treatment and prevention

The cornerstone of treatment for all stages is parenteral penicillin G, a discovery stemming from the work of Alexander Fleming. The specific formulation—such as benzathine penicillin G for early syphilis or aqueous crystalline penicillin G for neurosyphilis—is dictated by disease stage, as per guidelines from the World Health Organization and the CDC. For penicillin-allergic patients, alternatives like doxycycline or ceftriaxone may be used, though with caution. Prevention strategies focus on condom use, routine screening of high-risk populations and pregnant women, and prompt treatment of infected individuals and their sexual partners, known as partner notification, to break chains of transmission.

History and epidemiology

The bacterium was first identified in 1905 by Fritz Schaudinn and Erich Hoffmann in Berlin from syphilitic lesions. The infamous Tuskegee Syphilis Study, conducted by the U.S. Public Health Service, unethically tracked the natural progression of the disease in African American men from 1932 to 1972. Historically, syphilis was a major cause of morbidity in Europe, with figures like Al Capone and Franz Schubert believed to have been afflicted. Modern epidemiology shows resurgent rates, particularly among men who have sex with men and in regions with poor healthcare access. Global eradication efforts for the endemic treponematoses, led by the WHO, have significantly reduced the prevalence of yaws in countries like Papua New Guinea.

Category:Spirochaetes Category:Sexually transmitted diseases and infections Category:Bacteria described in 1905